Alpha 5-containing gamma-aminobutyric acid type A receptor (α5-GABA_A receptor)

The Alpha 5-containing gamma-aminobutyric acid type A receptor (α5-GABA_A receptor) is a specialized subtype of the GABA_A receptor family, primarily expressed in the hippocampus and cerebral cortex (UniProt, 2024). Unlike the more common synaptic GABA_A receptors that mediate fast phasic inhibition, α5-containing receptors are predominantly located extrasynaptically, where they provide sustained tonic inhibition that regulates the threshold for neuronal firing and synaptic plasticity (Soh & Lynch, 2015). This receptor plays a critical role in modulating cognitive processes, including spatial learning and memory consolidation (Atack, 2010). Dysregulation of α5-GABA_A receptor activity is implicated in several neuropsychiatric and neurodegenerative conditions, such as Alzheimer's disease, Down syndrome, and schizophrenia, where excessive tonic inhibition may contribute to cognitive deficits (Prevot et al., 2019). Pharmacological targeting of this receptor involves negative allosteric modulators (NAMs) to enhance cognition or positive allosteric modulators (PAMs) to treat mood disorders and promote neuroprotection (Knust et al., 2009). Due to its restricted brain distribution, it represents a promising target for precision medicine with a reduced risk of the sedative and ataxic side effects associated with non-selective GABAergic drugs.

Other names

GABRA5-containing receptorGABA(A) receptor subunit alpha-5Alpha-5 GABA-A receptorGABRA5

Negative allosteric modulation (NAM) of the benzodiazepine binding site to reduce tonic inhibition and enhance cognition; Positive allosteric modulation (PAM) to increase tonic inhibition for antidepressant or anxiolytic effects.